| scholarly article | Q13442814 |
| P2093 | author name string | Chao-Ping Wei | |
| Shao-Chun Ma | |||
| Wen-di Wang | |||
| Xing-Chang Zheng | |||
| Ye-Jun Wang | |||
| Ying-Jun Xu | |||
| Yu-Ping Sun | |||
| P2860 | cites work | Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease | Q80070420 |
| CD40 ligand gene and Kawasaki disease | Q80564571 | ||
| Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease | Q80738533 | ||
| Changes in causes of sudden deaths by decade in patients with coronary arterial lesions due to Kawasaki disease | Q81220703 | ||
| Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease | Q81231435 | ||
| Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) | Q81531506 | ||
| [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects] | Q81655152 | ||
| Diagnosis, treatment, and long-term management of Kawasaki disease | Q28171298 | ||
| Pharmacological therapy for patients with Kawasaki disease | Q28191172 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure | Q34139611 | ||
| Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients | Q34398833 | ||
| Kawasaki disease in children. | Q34807614 | ||
| Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease | Q35375519 | ||
| Dilated coronary arterial lesions in the late period after Kawasaki disease | Q35583550 | ||
| BNP or NTproBNP? A clinician's perspective. | Q37124035 | ||
| Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children | Q40549286 | ||
| Clinical spectrum of Kawasaki disease in infants. | Q40599592 | ||
| Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath | Q48220462 | ||
| The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure | Q48267455 | ||
| Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease | Q48510351 | ||
| B-type natriuretic peptide in paediatric patients with congenital heart disease | Q48656206 | ||
| Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. | Q51050982 | ||
| Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease | Q64380656 | ||
| P433 | issue | 2 | |
| P921 | main subject | Kawasaki disease | Q265936 |
| brain natriuretic peptide | Q66360952 | ||
| P304 | page(s) | 114-117 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | World journal of emergency medicine | Q26841808 |
| P1476 | title | Serum brain natriuretic peptide in children with Kawasaki disease | |
| P478 | volume | 1 |
Search more.